Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedDifference0.6%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.7%
- Check16 days agoChange DetectedDifference0.9%
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a clinical study on tuspetinib for treating acute myeloid leukemia and the addition of new identifiers and interventional model descriptions.SummaryDifference45%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 20, 2024.SummaryDifference0.6%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and its last update date of December 20, 2024.SummaryDifference0.5%
Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.